(Q51766967)

11 April 2018

title

Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. (English)

1 reference

11 April 2018

main subject

multiple sclerosis

0 references

cognitive dysfunction

1 reference

B A Parmenter

1

1 reference

11 April 2018

D R Denney

2

1 reference

11 April 2018

S G Lynch

3

1 reference

11 April 2018

L S Middleton

4

1 reference

11 April 2018

L M Harlan

5

1 reference

11 April 2018

publication date

1 January 2007

1 reference

11 April 2018

Multiple Sclerosis Journal

published in

1 reference

11 April 2018

volume

13

1 reference

11 April 2018

issue

1

1 reference

11 April 2018

page(s)

25-32

1 reference

11 April 2018

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E genotype does not influence the progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Association of APOE polymorphisms with disease severity in MS is limited to women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E controls the risk and age at onset of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Age at onset of Parkinson disease and apolipoprotein E genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Contribution of APOE promoter polymorphisms to Alzheimer's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070682

21 January 2018

Identifiers

DOI

10.1177/1352458506070682

1 reference

11 April 2018

1 reference

11 April 2018